Advancing Off-The-Shelf Immunotherapy for Solid Tumors: Using Gene-Edited iNK Cells

Time: 3:30 pm
day: Day Two


  • What are the important features for product-centric, ‘off-the-shelf’ immunotherapy, and how can we create this?
  • Establishing gene-editing and manufacture systems for functionally enhanced iPSC derived iNK cells
  • Translating allogeneic products to the clinic: the development of CTH-401